Diagnosis and Treatment of Non-Small Cell Lung Cancer - On Demand

Tuesday, August 31, 2021, 6:30 PM - Monday, August 22, 2022, 9:30 PM

Presented by Memorial Sloan Kettering’s (MSK) Physician Relations Team, Diagnosis and Treatment of Non-Small Cell Lung Cancer provides an overview of the screening, detection, treatment, and therapy for patients with early state and locally advanced lung cancers. MSK faculty, Bernard J. Park, MD, Daphna Gelblum, MD, and Michael Offin, MD, cover topics from current guidelines in early detections to following up with patients after treatment plans have been put in place.

This on demand program is complimentary for all. Select the 'Course Content' tab above to view the previously recorded lectures and Q&A. CME credit is offered for this on demand program and instructions can be found under course content.

This on demand program will be available until August 31, 2022.
Access to the videos and claiming credit will be available until August 31, 2022.

MSK’s Physician Relations Team is your direct connection to MSK physicians, information about the services offered in your area and assistance with the referral process to make it as seamless as possible for your patients. The Physician Relations Team will also keep you up to date on the numerous clinical trials MSK offers and inform you of our latest research and treatment advances. For further information about MSK's Physician Relations Team, please email [email protected].

1. Summarize current guidelines for low-dose CT screening for the early detection of lung cancer
2. Describe treatment options for early stage and locally advanced lung cancers
3. Describe the role of targeted therapy and immunotherapy in patients with non-small cell lung cancer
4. Summarize follow-up for patients after definitive treatment for early stage and locally advanced lung cancer

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: October 20, 2020; Original Release Date: August 31, 2021; Termination Date: August 31, 2022